We have revealed that PRL-3 can induce EMT through PTEN downregulation (Wang et al., 2007) and can lead to drug resistance of AML, implying the possibility of PRL-3 in tumor stem-like cell transition. The gene discussed is PTP4A3; the disease is acute myeloid leukemia.